OFI Advisors’s Haemonetics HAE Stock Holding History

OFI Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$458K	Buy	14,168 +1,306	+10%	+$49.1K	0.03%	751
2015 Q2	$532K	Buy	12,862 +1,008	+9%	+$42.5K	0.03%	703
2015 Q1	$532K	Sell	11,854 -300	-2%	-$12.5K	0.03%	693
2014 Q4	$455K	Sell	12,154 -84	-0.7%	-$3.08K	0.03%	736
2014 Q3	$427K	Sell	12,238 -430	-3%	-$15.3K	0.03%	719
2014 Q2	$447K	Buy	12,668 +2,231	+21%	+$74.5K	0.03%	698
2014 Q1	$340K	Buy	10,437 +2,708	+35%	+$103K	0.03%	810
2013 Q4	$326K	Buy	7,729 +1,568	+25%	+$64.5K	0.03%	794
2013 Q3	$246K	Buy	6,161 +1,331	+28%	+$55.8K	0.02%	848
2013 Q2	$200K	Buy	+4,830	New	+$196K	0.02%	881

Other funds holding HAE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

OFI Advisors's HAE Position: Q3 2015 in Review

OFI Advisors increased its Haemonetics (HAE) stake by 10% in Q3 2015, buying an estimated $49.1K and bringing the position to 14,168 shares worth $458K. The position accounts for 0.03% of the portfolio, ranked #751.

OFI Advisors first reported a position in HAE in Q2 2013 and has held it in 10 quarters since. The position peaked at $532K in Q2 2015. 171 funds tracked by Wall St. Rank hold HAE as of Q3 2015.

OFI Advisors held 14,168 shares of Haemonetics worth $458K as of Q3 2015.
OFI Advisors bought 1,306 Haemonetics shares in Q3 2015, an estimated $49.1K.
Haemonetics made up 0.03% of OFI Advisors's portfolio in Q3 2015, its #751 holding.
OFI Advisors first reported a position in Haemonetics in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Haemonetics position peaked at $532K in Q2 2015.
171 funds tracked by Wall St. Rank held Haemonetics as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.